These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18242086)

  • 1. Synthesis and evaluation of PSSRI-based inhibitors of Staphylococcus aureus multidrug efflux pumps.
    German N; Kaatz GW; Kerns RJ
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1368-73. PubMed ID: 18242086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
    Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A
    J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unlocking bacterial defense: Exploring the potent inhibition of NorA efflux pump by coumarin derivatives in Staphylococcus aureus.
    Martin ALAR; Pereira RLS; Rocha JE; Farias PAM; Freitas TS; Caldas FRL; Figueredo FG; Sampaio NFL; Oliveira-Tintino CDM; Tintino SR; da Hora GCA; Lima MCP; de Menezes IRA; Carvalho DT; Coutinho HDM; Fonteles MMF
    Microb Pathog; 2024 May; 190():106608. PubMed ID: 38503396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus.
    Kaatz GW; Moudgal VV; Seo SM; Hansen JB; Kristiansen JE
    Int J Antimicrob Agents; 2003 Sep; 22(3):254-61. PubMed ID: 13678830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
    Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
    Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
    Sangwan PL; Koul JL; Koul S; Reddy MV; Thota N; Khan IA; Kumar A; Kalia NP; Qazi GN
    Bioorg Med Chem; 2008 Nov; 16(22):9847-57. PubMed ID: 18848780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors.
    Astolfi A; Felicetti T; Iraci N; Manfroni G; Massari S; Pietrella D; Tabarrini O; Kaatz GW; Barreca ML; Sabatini S; Cecchetti V
    J Med Chem; 2017 Feb; 60(4):1598-1604. PubMed ID: 28117588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Modifications of the Quinolin-4-yloxy Core to Obtain New
    Cannalire R; Mangiaterra G; Felicetti T; Astolfi A; Cedraro N; Massari S; Manfroni G; Tabarrini O; Vaiasicca S; Barreca ML; Cecchetti V; Biavasco F; Sabatini S
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,3,4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureus.
    Naaz F; Khan A; Kumari A; Ali I; Ahmad F; Ahmad Lone B; Ahmad N; Ali Khan I; Rajput VS; Grover A; Shafi S
    Bioorg Chem; 2021 Aug; 113():105031. PubMed ID: 34089943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump.
    Sabatini S; Gosetto F; Manfroni G; Tabarrini O; Kaatz GW; Patel D; Cecchetti V
    J Med Chem; 2011 Aug; 54(16):5722-36. PubMed ID: 21751791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance.
    Sabatini S; Gosetto F; Iraci N; Barreca ML; Massari S; Sancineto L; Manfroni G; Tabarrini O; Dimovska M; Kaatz GW; Cecchetti V
    J Med Chem; 2013 Jun; 56(12):4975-89. PubMed ID: 23710549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in silico inhibitory effects of synthetic and natural eugenol derivatives against the NorA efflux pump in Staphylococcus aureus.
    Muniz DF; Dos Santos Barbosa CR; de Menezes IRA; de Sousa EO; Pereira RLS; Júnior JTC; Pereira PS; de Matos YMLS; da Costa RHS; de Morais Oliveira-Tintino CD; Coutinho HDM; Filho JMB; Ribeiro de Sousa G; Filho JR; Siqueira-Junior JP; Tintino SR
    Food Chem; 2021 Feb; 337():127776. PubMed ID: 32777574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering the Molecular Recognition Mechanism of Multidrug Resistance
    Palazzotti D; Bissaro M; Bolcato G; Astolfi A; Felicetti T; Sabatini S; Sturlese M; Cecchetti V; Barreca ML; Moro S
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31430864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel dihydronaphthalene-imidazole ligands as potential inhibitors of Staphylococcus aureus multidrug resistant NorA efflux pump: A combination of experimental and in silico molecular docking studies.
    A Malik A; Dangroo NA; Kaur P; Attery S; A Rather M; Khan A; Ara T; Nandanwar H
    Microb Pathog; 2024 May; 190():106627. PubMed ID: 38521473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-2 phenyl replacements to obtain potent quinoline-based
    Felicetti T; Mangiaterra G; Cannalire R; Cedraro N; Pietrella D; Astolfi A; Massari S; Tabarrini O; Manfroni G; Barreca ML; Cecchetti V; Biavasco F; Sabatini S
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):584-597. PubMed ID: 31992093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus.
    Rath SK; Singh S; Kumar S; Wani NA; Rai R; Koul S; Khan IA; Sangwan PL
    Bioorg Med Chem; 2019 Jan; 27(2):343-353. PubMed ID: 30552006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.
    Kumar A; Khan IA; Koul S; Koul JL; Taneja SC; Ali I; Ali F; Sharma S; Mirza ZM; Kumar M; Sangwan PL; Gupta P; Thota N; Qazi GN
    J Antimicrob Chemother; 2008 Jun; 61(6):1270-6. PubMed ID: 18334493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus aureus efflux pumps.
    Wei P; Kaatz GW; Kerns RJ
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3093-7. PubMed ID: 15149651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoguanidine hydrazones (AGH's) as modulators of norfloxacin resistance in Staphylococcus aureus that overexpress NorA efflux pump.
    Dantas N; de Aquino TM; de Araújo-Júnior JX; da Silva-Júnior E; Gomes EA; Gomes AAS; Siqueira-Júnior JP; Mendonça Junior FJB
    Chem Biol Interact; 2018 Jan; 280():8-14. PubMed ID: 29208359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dithiazole thione derivative as competitive NorA efflux pump inhibitor to curtail multi drug resistant clinical isolate of MRSA in a zebrafish infection model.
    Lowrence RC; Raman T; Makala HV; Ulaganathan V; Subramaniapillai SG; Kuppuswamy AA; Mani A; Chittoor Neelakantan S; Nagarajan S
    Appl Microbiol Biotechnol; 2016 Nov; 100(21):9265-9281. PubMed ID: 27531512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.